Skip to content

Role of Homoeopathic medicine in Low Back Pain

Effectiveness of individualized homoeopathic medicine in centesimal potency for the treatment of pain and disability in lumbosacral radiculopathy - A single arm pre and post interventional study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/096473
Enrollment
50
Registered
2025-10-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M541- Radiculopathy

Interventions

Intervention1: Individualized Homoeopathic medicine in Centesimal potency for 6 months: Medicine will be prescribed in Centesimal potency according to Homoeopathic principles regarding dose, potency a

Sponsors

National Institute of Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants of all gender, religion and socioeconomic status with lumbosacral radiculopathy Participants presenting with clinical features and radiological findings of lumbosacral radiculopathy X-ray finding of Lumbar/Sacral spondylosis with radiculopathy symptoms Radiological findings i.e. X-Ray, NCV, CT or MRI reports should be within 2 years Participants who can understand Bengali, Hindi or English Participants who are willing to give written consent to participate in the study

Exclusion criteria

Exclusion criteria: Cases with congenital lumbar and sacral anomalies (e.g., Sacralization of fifth lumbar- vertebrae, Spina bifida etc.) Persons with immunocompromised state and terminal or life threatening illness Participants shifting from one system of medicine to another system of medicine frequently Participant undergone lumbar spine surgery Lumbosacral radiculopathy with bone fracture Pregnant and Lactating women Participant with Psychiatric disorder

Design outcomes

Primary

MeasureTime frame
Oswestry Low Back Pain Disability Questionnaire scoreTimepoint: At baseline, 3 months and 6 months

Secondary

MeasureTime frame
MYMOP2 Questionnaire scoreTimepoint: At baseline, 3 months and 6 months

Countries

India

Contacts

Public ContactDr Chintamani Nayak

National Institute of Homoeopathy

drcnayak@gmail.com9433161854

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026